Does EZETIMIBE\ROSUVASTATIN Cause Ischaemic nephropathy? 11 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Ischaemic nephropathy have been filed in association with EZETIMIBE\ROSUVASTATIN. This represents 3.3% of all adverse event reports for EZETIMIBE\ROSUVASTATIN.
11
Reports of Ischaemic nephropathy with EZETIMIBE\ROSUVASTATIN
3.3%
of all EZETIMIBE\ROSUVASTATIN reports
0
Deaths
11
Hospitalizations
How Dangerous Is Ischaemic nephropathy From EZETIMIBE\ROSUVASTATIN?
Of the 11 reports, 11 (100.0%) required hospitalization.
Is Ischaemic nephropathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EZETIMIBE\ROSUVASTATIN. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does EZETIMIBE\ROSUVASTATIN Cause?
Myalgia (58)
Acute kidney injury (24)
Arthralgia (17)
Blood creatine phosphokinase increased (17)
Leriche syndrome (16)
Muscle spasms (16)
Peripheral arterial occlusive disease (16)
Asthenia (14)
Drug abuse (14)
Hepatic cytolysis (12)
What Other Drugs Cause Ischaemic nephropathy?
PANTOPRAZOLE (22)
LANSOPRAZOLE (21)
OMEPRAZOLE (21)
AMLODIPINE\PERINDOPRIL (11)
BISOPROLOL (11)
CLOPIDOGREL BISULFATE (11)
EMPAGLIFLOZIN (11)
INCLISIRAN (11)
RIVAROXABAN (11)
TORSEMIDE (11)
Which EZETIMIBE\ROSUVASTATIN Alternatives Have Lower Ischaemic nephropathy Risk?
EZETIMIBE\ROSUVASTATIN vs EZETIMIBE\SIMVASTATIN
EZETIMIBE\ROSUVASTATIN vs EZOGABINE
EZETIMIBE\ROSUVASTATIN vs FACTOR XIII CONCENTRATE
EZETIMIBE\ROSUVASTATIN vs FAM-TRASTUZUMAB DERUXTECAN-NXKI
EZETIMIBE\ROSUVASTATIN vs FAMCICLOVIR